This segment encompasses the chain retail business of medicines, Chinese herbal medicine slices, ginseng and antler tonics, health products, medical devices, personal care products, and household products. DaShenLin operates a vast network of pharmacies across China, providing a wide range of pharmaceutical products and healthcare services directly to consumers. The company focuses on expanding its retail footprint and enhancing its supply chain to ensure product availability and efficient distribution. This segment's success is driven by its ability to meet the diverse healthcare needs of the Chinese population, offering both Western and traditional Chinese medicines. Future growth will likely come from expanding its retail network and increasing its product offerings.

DaShenLin's manufacturing segment focuses on the production of a wide array of pharmaceutical products, including both Chinese and Western medicines. The company invests in research and development to create new and innovative drugs, as well as improve existing formulations. This segment utilizes advanced manufacturing technologies to ensure high-quality production and efficient scaling. The company's manufacturing operations are subject to stringent regulatory compliance, including adherence to Good Manufacturing Practices (GMP). The company's manufacturing capabilities support its retail and wholesale operations, ensuring a consistent supply of products. Future opportunities include expanding its product portfolio and entering new therapeutic areas.